It is believed that IVMacts on gamma-amino butyric acid (GABA) receptor and glutamate-gated chloride channels. 3 Due to the low affinity for other mammalian ligand-gated channels, IVM hardly crosses the blood-brain barrier. Consequently, IVM has been generally supposed to be of low toxicity for the health of adults and approved for use in humans worldwide. 4 For example, IVM was widely used for the treatment of river blindness in the form of a free drug, saving countless people's eyesight. 5 The discoverers of IVM were awarded the 2015 Nobel Prize in Physiology or Medicine due to it has a very successful therapeutic effect on many parasitic diseases. 6 In the recent years, IVM has been reported to exert anticancer activities. However, the specific roles of IVM in cancer remain unclear.
Cancer is a group of diseases with characteristics involving abnormal and uncontrolled cell growth, the potential for penetration and diffusion to other parts of body, considered as the leading cause of death in the world. 7 Therefore, the research of antitumour drugs with high efficiency and low toxicity has been the focus of drug discovery. 8 The HeLa cell line derived from cervical cancer cells was the first successful attempt to immortalize human-derived cells in vitro and has served a role analogous to that of a model organism due to its robust growth and unrestricted distribution. 9 Cervical cancer is one of the most common malignancy throughout the world which has become the second female malignant tumour, and has a serious threat to the health and safety of women. 10 Based on these two points above, we chose to use HeLa cells for our study.
Ivermectin has been demonstrated to have anticancer activities on various types of cancer including glioblastoma, chronic myelogenous leukaemia and breast cancer. [11] [12] [13] Because of the lack of systematic research on the anticancer activity of IVM in HeLa cells, the aim of this study was to investigate the activity and underlying mechanism of IVM against HeLa cells, and to provide experimental basis and theoretical foundation for further research on theory and clinical study. 
| MATERIAL S AND ME THODS

| Chemicals and antibodies
| Cell culture
HeLa cell line (Human cervical carcinoma) was acquired from ATCC and grown in DMEM medium (Hyclone, Logan, UT, USA) supplemented with 10% FBS (Gibco, USA) and 1% penicillin/streptomycin (Hyclone) in an incubator with a humidified air atmosphere of 5% CO 2 at 37°C.
| Cell viability assay
The MTT colorimetric method is a method that can quickly quantify the number and the value-added state of living cells. 14 It is widely used for cytotoxicity detection due to its advantages such as small workload, easy operation, rapidity and good repeatability. 15 The 
| Cell cycle analysis
The HeLa cells (1 × 10 6 cells/well) were seeded onto 9.6 cm 2 plates overnight and treated with specified concentrations (0, 2. added 100 μL propidium iodide solution (500 μg/mL) to the cells and incubated for 15 minutes in the dark. 16 The cell cycle was then analysed by flow cytometry (BD FACS Calibur). Data were analysed by the Flowjo software.
| DNA damage assay
The neutral comet assay was used to study the DNA damage induced by IVM. 
| Chromatin condensation detection
HeLa cells were seeded (1 × 10 5 cells/well) in a 12-well plate and incubated overnight. Then, the cells were exposed to IVM (0, 2.5, 5, 10 and 20 μmol/L) for 24 hours. After fixed with paraformaldehyde, the cells were stained by DAPI (1 μL/well, 1 μg/mL) for 15 minutes at 37°C. Changes in nuclear morphology induced by IVM were observed using fluorescent microscopy.
| Flow cytometry analysis of cell apoptosis
Apoptosis rate was determined using the Alexa 
| Mitochondrial membrane potential (ΔΨm) analysis
The effect of IVM on mitochondrial membrane potential was assessed using fluorescence microscopy. HeLa cells were seeded ( 
| Western blotting
| Intracellular ROS measurement
The effect of IVM on intracellular reactive oxygen species was evaluated by fluorescence microscopy. 18 HeLa cells were seeded ( The phenomenon of cells was photographed by fluorescence microscopy. The images were measured using Imagej software.
| Antimigration assay
We use scratch test to analyse the antimigration potential of IVM.
HeLa cells (1 × 10 5 cells/well) were seeded in 6-well plate. When the cell density reaches about 70%, we use a 200 μl yellow pipette tip to draw a straight line in the cell culture plate. 19 Since antimetastatic agents usually require long-term use by patients, they should have low cytotoxicity. Therefore, in the current study, we have used IVM at lower concentrations than that used for other assays (2.5, 5, 10, 15 μmol/L). After scratching, HeLa cells were exposed to different concentrations of IVM for 48 hours. The images of cell migration were captured using fluorescence microscopy. The data analysis was performed using Imagej soft-ware.
| Data analyses
At least three independent biological replicates were performed in all experiments. Data were shown as mean ± standard deviation. To determine differences between groups, we performed the Dunnett test using ANOVA (P < 0.05 indicates statistical significance). SPSS 17.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.
| RE SULTS
| Inhibition of HeLa cells viability by IVM
To evaluate the cytotoxic of IVM on HeLa cells, we analysed the cell viability using the MTT assay. IVM can significantly inhibit the activity of HeLa cells in a time-and dose-dependent manner 
| IVM-induced cell cycle arrest at G1/S phase
Flow cytometry of propidium iodide staining was performed to analyse the cell cycle distribution. As is shown in Figure 2A 
| IVM-induced DNA damage in HeLa cells
We used single-cell gel electrophoresis (comet assay) to evaluate the DNA damage induced by IVM. During electrophoresis, the broken DNA fragments move towards the positive electrode by carrying a negative charge, and the unbroken DNA does not move. After staining, the nucleus forms a bright head, and the DNA fragments form a tail, which resembles a comet-like shape. The more severe the DNA damage, the longer the tail length. It can be seen from the Figure 3A that the nuclear chromatin DNA of the untreated control group of IVM is basically not broken, the nucleus is intact, and it is round, and no obvious comet-like tail is observed. However, the nuclear chromatin DNA of the treatment group is obviously broken and formed a long comet-like tail, the "tailing" phenomenon. The percentages of comet-positive cells of HeLa increased significantly after treated by IVM in a dose-dependent way ( Figure 3B ). The distributions of IVMtreatment HeLa cells, with respect to comet assay parameters including tail lengths and tail DNA are presented in Table 2 (**P < 0.01).
The results showed that there was no obvious DNA damage in the untreated control group, and the DNA damage of HeLa cells was significantly improved after IVM treatment.
| IVM-induced apoptosis in HeLa cells
After treatment with different concentrations of IVM for 24 hours, IVM-induced apoptosis was measured by flow cytometry ( Figure 4A ). The different labelling patterns in the annexin V/PI analysis were used to identify the different cell populations where Small alphabet indicated statistically significant differences between two groups in the same column (P < 0.05).
TA 
| IVM-induced mitochondrial membrane potential collapse in HeLa cells
Mitochondrial membrane potential (MMP) is one of the important indicators for maintaining normal mitochondrial configuration and function. 20 Decreased MMP is one of the important factors leading to apoptosis and is considered to be the first step of the apoptosis cascade. 21 Therefore, we tried to evaluate the influence of IVM on MMP in HeLa cells. We found that exposure of HeLa cells to different concentrations (0, 2.5, 5, 10 and 20 μmol/L) of IVM for 6 hours resulted in a gradual decrease in green fluorescence intensity ( Figure 5A ,B). The study shows that the decrease of MMP was brought about by IVM treatment in HeLa cells (**P < 0.01).
| Effect of IVM on the expression of apoptosisrelated proteins in HeLa cells
The role of mitochondria in the mechanism of apoptosis has at- 
| Effect of IVM on caspase-3, caspase-9,P53 and PARP in HeLa cells
The process of apoptosis involves a complex cascade of proteolytic hydrolysis. 22 The Caspase family plays an extremely important role in the process of apoptosis. 23 P53 is a tumour suppressor protein that plays an important role in the mitochondrial apoptosis pathway. 24 To further investigate the apoptosis of HeLa cells caused by IVM, we examined the activity of caspase-3, caspase-9, p53 and PARP by Western blot assay. As shown in Figure 7 , caspase-3 and The data are shown as the means ± SD of three independent experiments. Small alphabet indicated statistically significant differences between any two groups in the same column (P < 0.05).
caspase-9 were both activated while cleaved PARP increased and P53 protein expression was significantly increased.
| IVM-induced generation of intracellular ROS in HeLa cells
We analysed the intracellular reactive oxygen species (ROS) level using fluorescence microscopy after DCFH-DA being hatched in 
| Migration of HeLa Cells was Inhibited by IVM
We further verified the inhibitory effect of IVM on HeLa cell migration using antimigration assay ( Figure 9A ). Since higher concentrations of IVM may cause apoptosis, this study was performed at lower concentrations to confirm the antimigratory potential. After 48 hours of incubation, the cells in the control group gradually began to heal and grow into dense cell clusters, and in cells treated with 
| D ISCUSS I ON
In recent years, the use of bacterial or fungal fermentation to prevent and treat cancer is attracting more and more attention. 25 IVM is a semi-synthetic macrocyclic lactone derivative of the avermectin family. 26 Nowadays, because of it has no side effects on human safety, IVM has been approved for use in humans to treat on chocerciasis and lymphatic filariasis. 27 Accumulating evidence suggests that IVM has anticancer activities against breast cancer, ovarian cancer, neurofibromatosis and chronic myeloid leukaemia. In our study,
we investigated the effects of IVM on cervical cancer (HeLa) cell line and explored the underlying mechanisms.
To evaluate the cytotoxicity of IVM on HeLa cells, we used the MTT assay to assess the effects of different concentrations of IVM on the viability of HeLa cells. The results showed that IVM has a significant inhibitory effect on theproliferation of HeLa cells.
Meanwhile, the result of alkaline comet assay analysis indicated that IVM inducing DNA fragmentation in HeLa cells. As we all know, DNA damage can induce inactivation of the CDK-Cyclin complex, resulting in cell cycle arrest. 28 Cell cycle progression is one of a pivotal signalling mechanisms of homoeostasis maintenance in healthy tissues and normal cells. 29 Therefore, induction of cell arrest in cancer cells is one of the useful strategies for anticancer drug development.
30
Cell cycle analysis shows that IVM induces G1/S cycle arrest in HeLa cells, which means that IVM inhibits proliferation of HeLa cells via cell cycle arrest resulting from DNA damage.
It is well known that three pathways can lead to cell death, namely apoptosis, autophagy and cell necrosis. 31 At present, targeting apoptosis is the most successful way to treat cancer in addition to surgery. We further designed experiments to explore whether IVM can cause apoptosis in HeLa cells. Through DAPI staining, we clearly observed the obvious morphological features of apoptosis such as cell shrinkage, chromatin condensation and As we all know, the apoptosis pathway is divided into two major types: intrinsic pathway (mediated by mitochondria) and the extrinsic pathway (mediated by death receptors). Rapid metastasis is one of the biggest malignant features of cancer cells. 35 The invasion and metastasis of malignant tumours are a series of complex and multi-step interactions. 36 It involves the malignant proliferation of cancer cells, the adhesion of tumour cells, movement, invasiveness and the ability to metastasize. Tumour invasion is the premise of cancer metastasis. 37 Invasion does not mean that metastasis must occur. However, tumour metastasis must invade. 38 We determined that IVM can significantly inhibit the migration of HeLa cells by the scratch test.
In conclusion, we have demonstrated that IVM can significantly inhibit the proliferation of HeLa cells via cell cycle arrest resulting from DNA damage, and induced apoptosis of HeLa cells through the mitochondrial pathway. At the same time, we found that IVM can inhibit its migration activity significantly. Through these studies, we determined that IVM has significant anticancer activity against HeLa cells. However, the study of the effect of IVM on cancer in vivo has not yet been carried out. This will be the focus of our future work. . Data were calculated by mean ± SD of three independent experiments. **P < 0.01. IVM, ivermectin
